Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass

Journal of the American College of Cardiology

Volumn 56, Issue 22, 2010, Pages 1794-1802

  Gruenwald, Colleen E ^a,c   Manlhiot, Cedric ^a   Chan, Anthony K ^b   Crawford Lean, Lynn ^a   Foreman, Celeste ^a   Holtby, Helen M ^a   Van Arsdell, Glen S ^a   Richards, Ross ^c   Moriarty, Helen ^c   McCrindle, Brian W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PROTAMINE; THROMBIN;

ANTI XA ASSAY; ANTICOAGULATION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; GROUPS BY AGE; HEART SURGERY; HEMODILUTION; HEMOSTASIS; HEMOSTASIS MANAGEMENT SYSTEM; HUMAN; INFANT; INTENSIVE CARE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; PATIENT SAFETY; PEDIATRIC SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SURGERY ARISTOTLE SCORE; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEMOSTASIS, SURGICAL; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; PROTAMINES; SINGLE-BLIND METHOD;

EID: 78449282703     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.046     Document Type: Article

References (39)

1. G.D. Williams, S.L. Bratton, E.C. Riley, and C. Ramamoorthy Association between age and blood loss in children undergoing open heart operations Ann Thorac Surg 66 1998 870 875
2. H.H. Hovels-Gurich, K. Schumacher, and J.F. Vazquez-Jimenez Cytokine balance in infants undergoing cardiac operation Ann Thorac Surg 73 2002 601 608
3. J.J. Jaggers, M.C. Neal, P.K. Smith, R.M. Ungerleider, and J.H. Lawson Infant cardiopulmonary bypass: a procoagulant state Ann Thorac Surg 68 1999 513 520
4. F.H. Kern, N.J. Morana, J.J. Sears, and P.R. Hickey Coagulation defects in neonates during cardiopulmonary bypass Ann Thorac Surg 54 1992 541 546
5. A.K. Chan, M. Leaker, and F.A. Burrows Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass Thromb Haemost 77 1997 270 277
6. G.D. Williams, S.L. Bratton, and C. Ramamoorthy Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery Anesth Analg 89 1999 57 64
7. P. Monagle, C. Barnes, and V. Ignjatovic Developmental haemostasis Impact for clinical haemostasis laboratories Thromb Haemost 95 2006 362 372
8. M. Andrew, B. Paes, and R. Milner Development of the human coagulation system in the full-term infant Blood 70 1987 165 172
9. C. Gruenwald, C. Manlhiot, and L. Crawford-Lean Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery J Extra Corpor Technol 42 2010 9 19
10. M.D. Boisclair, D.A. Lane, and H. Philippou Mechanisms of thrombin generation during surgery and cardiopulmonary bypass Blood 82 1993 3350 3357
11. T.F. Slaughter, T.H. LeBleu, J.M. Douglas Jr., J.B. Leslie, J.K. Parker, and C.S. Greenberg Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers Anesthesiology 80 1994 520 526
12. S.O. Turner-Gomes, L. Mitchell, W.G. Williams, and M. Andrew Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations J Thorac Cardiovasc Surg 107 1994 562 568
13. A.T. Culliford, S.N. Gitel, and N. Starr Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass Ann Surg 193 1981 105 111
14. C. D'Errico, J.R. Shayevitz, and S.J. Martindale Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients J Cardiothorac Vasc Anesth 10 1996 451 457
15. M. Jaberi, W.R. Bell, and D.W. Benson Control of heparin therapy in open-heart surgery J Thorac Cardiovasc Surg 67 1974 133 141
16. V.F. Olshove, J. Langwell, J. Burnside, and D. Bennett Heparin dose response in pediatric cardiopulmonary bypass J Extra Corpor Technol 26 1994 126 128
17. H.G. Schriever, S.E. Epstein, and M.D. Mintz Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time Am J Clin Pathol 60 1973 323 329
18. N.A. Guzzetta, T. Bajaj, and T. Fazlollah A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass Anesth Analg 106 2008 419 425
19. N.A. Guzzetta, B.E. Miller, K. Todd, F. Szlam, R.H. Moore, and S.R. Tosone An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates Anesth Analg 100 2005 1276 1282
20. M. Codispoti, C.A. Ludlam, D. Simpson, and P.S. Mankad Individualized heparin and protamine management in infants and children undergoing cardiac operations Ann Thorac Surg 71 2001 922 927
21. G.J. Despotis, K.S. Filos, V. Levine, A. Alsoufiev, and E. Spitznagel Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro Anesth Analg 82 1996 1126 1131
22. A. Koster, T. Fischer, and M. Praus Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management Anesthesiology 97 2002 837 841
23. A. Koster, S. Huebler, and F. Merkle Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response Anesth Analg 98 2004 285 290
24. G.J. Despotis, J.H. Joist, and C.W. Hogue Jr. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT Thromb Haemost 76 1996 902 908
25. P.D. Raymond, M.J. Ray, S.N. Callen, and N.A. Marsh Heparin monitoring during cardiac surgery Part 1: validation of whole-blood heparin concentration and activated clotting time Perfusion 18 2003 269 276
26. P.D. Raymond, M.J. Ray, S.N. Callen, and N.A. Marsh Heparin monitoring during cardiac surgery Part 2: calculating the overestimation of heparin by the activated clotting time Perfusion 18 2003 277 281
27. G.J. Despotis, V. Levine, D. Joiner-Maier, and J.H. Joist A comparison between continuous infusion versus standard bolus administration of heparin based on monitoring in cardiac surgery Blood Coagul Fibrinolysis 8 1997 419 430
28. M. Harloff, J. Taraskiewicz, and C. Fotouhi Comparison study of the Hepcon System Four and the Hemostasis Management System Perfusion 6 1991 297 301
29. G.J. Despotis, G. Gravlee, K. Filos, and J. Levy Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques Anesthesiology 91 1999 1122 1151
30. M. Elliott Modified ultrafiltration and open heart surgery in children Paediatr Anaesth 9 1999 1 5
31. S.S. Mou, B.P. Giroir, and E.A. Molitor-Kirsch Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants N Engl J Med 351 2004 1635 1644
32. M. Andrew, P. Vegh, M. Johnston, J. Bowker, F. Ofosu, and L. Mitchell Maturation of the hemostatic system during childhood Blood 80 1992 1998 2005
33. J.R. Shayevitz, and S.W. O'Kelley A reappraisal of anticoagulation and heparin neutralization for cardiopulmonary bypass in pediatrics J.B. Eisenkraft, Progress in Anesthesiology Vol 9 1995 Dannemiller Memorial Education Foundation San Antonio, TX 275 296
34. S. Svenmarker, M. Appelblad, E. Jansson, and S. Haggmark Measurement of the activated clotting time during cardiopulmonary bypass: differences between Hemotec ACT and Hemochron Jr apparatus Perfusion 19 2004 289 294
35. J. Guay, and G.E. Rivard Mediastinal bleeding after cardiopulmonary bypass in pediatric patients Ann Thorac Surg 62 1996 1955 1960
36. D.R. Jobes, S.C. Nicolson, J.M. Steven, and C.S. Manno Coagulation defects in neonates during cardiopulmonary bypass Ann Thorac Surg 55 1993 1283 1284
37. C.L. Lake Pediatric Cardiac Anesthesia 3rd edition 2005 Appleton & Lange Norwalk, CT
38. M. Andrew, B. MacIntyre, and J. MacMillan Heparin therapy during cardiopulmonary bypass in children requires ongoing quality control Thromb Haemost 70 1993 937 941
39. F. Ni Ainle, R.J. Preston, and P.V. Jenkins Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation Blood 114 2009 1658 1665